Market By Product, Application, And Geography | Forecast 2019-2028
Triton Market Research has concluded that the North America opioid drugs market is projected to grow at a CAGR of 2.36% in the estimated years 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries assessed in the report on this market include:
• The United States
• Canada
Canada is currently facing one of the worst public health crises to have happened in recent years. In the period from January 2016 to September 2018, there were more than 10,300 opioid related deaths in the country. Canada follows the United States, ranking at the second position in the world, when it excessive opioid consumption. Just like in the United States, the excessive consumption of opioids in the country is a major factor leading to this crisis.
As per findings, Purdue Pharma Canada made certain misleading marketing claims, which influenced opioid prescribing practices. Consequently, a group of physicians and opioid experts in the country wrote to the federal government, demanding criminal investigation against the pharma giant. Further, the product monograph of OxyContin showed misleading information, understating the risks associated with its use. The Canadian government has therefore been working proactively, collaborating with provinces, territories, and other partners across the nation, to tackle this issue.
Further, with the help of the Canadian Institutes of Health Research (CIHR), the federal government launched the Canadian Research Initiative in Substance Misuse (CRISM). This initiative was launched with the aim of conducting research on best practices to prevent and treat substance abuse, also including opioid addiction. These efforts promote the responsible use of opioid drugs, thereby favoring the market growth in the region.
Acura Pharmaceuticals is a US-based pharma tech development company. It is engaged in the research, development, and manufacture of APIs used as raw materials for producing pharmaceutical products. The company has developed technologies for use in products for narcotic-based pain management. The company operates in the US, in the regions of Illinois, Indiana, and Philadelphia.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1.   NORTH AMERICA OPIOID DRUGS MARKET - SUMMARY
2.   INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1. NEW OPPORTUNITIES FOR PHARMACEUTICAL COMPANIES IN THE US
2.2.2. TECHNOLOGICAL ADVANCEMENTS TO FIGHT AGAINST OPIOID DRUG CRISIS
2.2.3. DIFFERENT SOURCES OF PROCURING OPIOIDS
2.3. PORTER’S FIVE FORCE ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE
2.3.3. BARGAINING POWER OF SUPPLIERS
2.3.4. BARGAINING POWER OF BUYERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1. GROWTH IN MEDICAL CASES & RISING PREVALENCE OF CANCER
2.6.2. INCREASE IN THE USE OF ABUSE-DETERRENT FORMULATIONS TO RESTRICT THE RISE OF OPIOID DEPENDENCE
2.6.3. DEMAND FOR PALLIATIVE THERAPY
2.7. MARKET RESTRAINTS
2.7.1. GOVERNMENT RULES AND REGULATIONS
2.7.2. INCREASED NUMBER OF LAWSUITS AGAINST THE MANUFACTURERS OF OPIOD DRUGS
2.7.3. USAGE OF OPIOIDS FOR NON-MEDICAL PURPOSES
2.8. MARKET OPPORTUNITIES
2.8.1. RISING COMMERCIAL SUCCESS AND MARKET SHARE OF OPIOID DRUGS
2.8.2. GROWTH OF INVESTMENTS IN RESEARCH OF PHARMACEUTICAL USES OF OPIOIDS
2.9. MARKET CHALLENGES
2.9.1. OPIOID EPIDEMIC SPREADING
2.9.2. RISING DEATH RATE DUE TO OPIOID OVERDOSE
2.10. COVID-19 IMPACT ON THE OPIOID DRUGS MARKET
3.   NORTH AMERICA OPIOID DRUGS MARKET OUTLOOK - BY PRODUCT
3.1. BUPRENORPHINE
3.2. FENTANYL
3.3. HYDROCODONE
3.4. MORPHINE
3.5. OXYCODONE
3.6. TRAMADOL
3.7. OTHER PRODUCTS
4.   NORTH AMERICA OPIOID DRUGSS MARKET OUTLOOK - BY APPLICATION
4.1. PAIN RELIEF
4.1.1. CANCER PAIN
4.1.2. POSTOPERATIVE PAIN MANAGEMENT
4.1.3. LOWER BACK PAIN
4.1.4. ORTHOPEDIC
4.1.5. NEUROPATHIC
4.1.6. FIBROMYALGIA
4.2. ANESTHESIA
4.3. COUGH SUPPRESSION
4.4. DIARRHEA SUPPRESSION
4.5. DE-ADDICTION
5.   NORTH AMERICA OPIOID DRUGS MARKET – REGIONAL OUTLOOK
5.1. UNITED STATES
5.2. CANADA
6.   COMPETITIVE LANDSCAPE
6.1. ACURA PHARMACEUTICALS
6.2. BIODELIVERY SCIENCES INTERNATIONAL INC
6.3. CIPHER PHARMACEUTICALS INC
6.4. ALLERGAN (ACQUIRED BY ABBVIE)
6.5. COLLEGIUM PHARMACEUTICAL INC
6.6. DAIICHI SANKYO
6.7. HIKMA PHARMACEUTICALS PLC
6.8. INDIVIOR INC
6.9. JANSSEN PHARMACEUTICALS INC
6.10. JOHNSON JOHNSON
6.11. LANNETT CO INC
6.12. LUPIN LTD
6.13. MYLAN NV
6.14. PFIZER INC
6.15. PURDUE PHARMA LP
6.16. SANOFI-AVENTIS SA
6.17. SUN PHARMACEUTICAL INDUSTRIES LTD
6.18. TEVA PHARMACEUTICAL INDUSTRIES LTD
7.   METHODOLOGY & SCOPE
7.1. RESEARCH SCOPE & DELIVERABLES
7.2. SOURCES OF DATA
7.3. RESEARCH METHODOLOGY
TABLE 1: NORTH AMERICA OPIOID DRUGS MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: NORTH AMERICA OPIOID DRUGS MARKET, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA OPIOID DRUGS MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 5: NORTH AMERICA OPIOID DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA OPIOID DRUGS MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCE ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: NORTH AMERICA OPIOID DRUGS MARKET, BY BUPRENORPHINE, 2019-2028 (IN $ MILLION)
FIGURE 4: NORTH AMERICA OPIOID DRUGS MARKET, BY FENTANYL, 2019-2028 (IN $ MILLION)
FIGURE 5: NORTH AMERICA OPIOID DRUGS MARKET, BY HYDROCODONE, 2019-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA OPIOID DRUGS MARKET, BY MORPHINE, 2019-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA OPIOID DRUGS MARKET, BY OXYCODONE, 2019-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA OPIOID DRUGS MARKET, BY TRAMADOL, 2019-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA OPIOID DRUGS MARKET, BY OTHER PRODUCTS, 2019-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA OPIOID DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA OPIOID DRUGS MARKET, BY CANCER PAIN, 2019-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA OPIOID DRUGS MARKET, BY POSTOPERATIVE PAIN MANAGEMENT, 2019-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA OPIOID DRUGS MARKET, BY LOWER BACK PAIN, 2019-2028 (IN $ MILLION)
FIGURE 14: NORTH AMERICA OPIOID DRUGS MARKET, BY ORTHOPEDIC, 2019-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA OPIOID DRUGS MARKET, BY NEUROPATHIC, 2019-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA OPIOID DRUGS MARKET, BY FIBROMYALGIA, 2019-2028 (IN $ MILLION)
FIGURE 17: NORTH AMERICA OPIOID DRUGS MARKET, BY ANESTHESIA, 2019-2028 (IN $ MILLION)
FIGURE 18: NORTH AMERICA OPIOID DRUGS MARKET, BY COUGH SUPPRESSION, 2019-2028 (IN $ MILLION)
FIGURE 19: NORTH AMERICA OPIOID DRUGS MARKET, BY DIARRHEA SUPPRESSION, 2019-2028 (IN $ MILLION)
FIGURE 20: NORTH AMERICA OPIOID DRUGS MARKET, BY DE-ADDICTION, 2019-2028 (IN $ MILLION)
FIGURE 21: NORTH AMERICA OPIOID DRUGS MARKET; REGIONAL OUTLOOK 2019 & 2028 (IN %)
FIGURE 22: UNITED STATES OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 23: CANADA OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)